Non-Invasive Prenatal Screening (NIPS) also know as Non-Invasive Prenatal Testing (NIPT) is a relatively new non-invasive blood test that measures the amount of cell-free fetal DNA circulating in maternal serum. NIPS accurately measures the quantity variance of fetal and maternal chromosomal material and provides a screen risk for Down syndrome (trisomy 21), trisomy 18, and trisomy 13. The Down syndrome detection rate is >99% with a false positive rate of 0.1%.
Use the tabs below for more information on Funded NIPS and Self-Pay NIPS.